CVRx, Inc.
CVRx, Inc. (CVRX) Financial Performance & Income Statement Overview
Explore the financials of CVRx, Inc. (CVRX), including yearly and quarterly data on income, cash flow, and balance sheets.
CVRx, Inc. (CVRX) Income Statement & Financial Overview
View the income breakdown for CVRx, Inc. CVRX across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $12.35M | $15.34M | $13.37M | $11.81M |
| Cost of Revenue | $2.04M | $2.30M | $2.25M | $2.04M |
| Gross Profit | $10.31M | $13.04M | $11.13M | $9.77M |
| Gross Profit Ratio | $0.84 | $0.85 | $0.83 | $0.83 |
| R&D Expenses | $2.52M | $2.81M | $2.50M | $2.77M |
| SG&A Expenses | $21.23M | $20.51M | $21.63M | $20.97M |
| Operating Expenses | $23.75M | $23.32M | $24.14M | $23.74M |
| Total Costs & Expenses | $25.79M | $25.62M | $26.38M | $25.78M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$1.46M | $1.52M | $958000.00 | $959000.00 |
| Depreciation & Amortization | $0.00 | $178000.00 | $169000.00 | $141000.00 |
| EBITDA | -$13.44M | -$13.62M | -$11.93M | -$12.89M |
| EBITDA Ratio | -$1.09 | -$0.89 | -$0.89 | -$1.09 |
| Operating Income | -$13.44M | -$10.27M | -$13.01M | -$13.97M |
| Operating Income Ratio | -$1.09 | -$0.67 | -$0.97 | -$1.18 |
| Other Income/Expenses (Net) | -$334000.00 | -$448000.00 | -$41000.00 | -$15000.00 |
| Income Before Tax | -$13.77M | -$10.72M | -$13.05M | -$13.99M |
| Income Before Tax Ratio | -$1.12 | -$0.70 | -$0.98 | -$1.18 |
| Income Tax Expense | $5000.00 | -$71000.00 | $47000.00 | $41000.00 |
| Net Income | -$13.77M | -$10.65M | -$13.10M | -$14.03M |
| Net Income Ratio | -$1.11 | -$0.69 | -$0.98 | -$1.19 |
| EPS | -$0.53 | -$0.39 | -$0.57 | -$0.65 |
| Diluted EPS | -$0.53 | -$0.39 | -$0.57 | -$0.65 |
| Weighted Avg Shares Outstanding | $25.88M | $22.60M | $22.78M | $21.63M |
| Weighted Avg Shares Outstanding (Diluted) | $25.88M | $22.60M | $22.78M | $21.63M |
Over the past four quarters, CVRx, Inc. demonstrated steady revenue growth, increasing from $11.81M in Q2 2024 to $12.35M in Q1 2025. Operating income reached -$13.44M in Q1 2025, maintaining a consistent -109% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$13.44M, reflecting operational efficiency. Net income dropped to -$13.77M, with EPS at -$0.53. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan